Glimet Tablet 1 mg contains Repaglinide, an oral antidiabetic medication used in the management of type 2 diabetes mellitus. Repaglinide belongs to the class of meglitinides, which work by stimulating the pancreas to release insulin in response to meals. This action helps control postprandial blood glucose spikes, a critical factor in maintaining overall glycemic control.
Glimet is particularly useful for patients who experience irregular meal schedules or require flexible dosing, as it has a rapid onset and short duration of action. This allows for targeted management of blood sugar surges after eating, while minimizing the risk of prolonged hypoglycemia.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Glimet Tablet 1 mg is indicated for:
Type 2 diabetes mellitus in adults when diet, exercise, and lifestyle changes alone are insufficient to maintain blood sugar levels
Patients with high postprandial glucose levels
As monotherapy in patients unable to tolerate other antidiabetic drugs
In combination with metformin or other oral hypoglycemic agents when monotherapy does not provide adequate glycemic control
Glimet is not suitable for type 1 diabetes, diabetic ketoacidosis, or severe liver/kidney impairment.
Adults: The usual starting dose is 1 mg taken orally before each main meal, up to 30 minutes prior to eating
The dose may be adjusted based on blood glucose levels and physician guidance, typically ranging from 0.5 mg to 4 mg per meal
Swallow the tablet with a full glass of water, and do not skip meals after taking Glimet to avoid hypoglycemia
Regular blood glucose monitoring is recommended to ensure optimal dosing
Consistent adherence to diet and exercise plans is essential for effective diabetes management
Provides rapid reduction of postprandial blood glucose, supporting overall glycemic control
Flexible dosing with meals reduces the risk of prolonged hypoglycemia
Can be used as monotherapy or in combination with other antidiabetic agents for tailored therapy
Helps prevent long-term complications of diabetes, including neuropathy, retinopathy, and cardiovascular disease
Well-tolerated with a short duration of action, minimizing side effects compared to some sulfonylureas
Glimet Tablet 1 mg is generally well tolerated. Common side effects include:
Hypoglycemia (low blood sugar), particularly if meals are skipped or delayed
Mild gastrointestinal symptoms: nausea, diarrhea, or stomach discomfort
Headache, dizziness, or fatigue
Rare allergic reactions: rash, itching, or swelling
Very rare: liver enzyme elevation or changes in blood counts
Patients should carry a fast-acting sugar source to manage hypoglycemia and report severe or persistent symptoms to their healthcare provider.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Avoid use in type 1 diabetes, diabetic ketoacidosis, or severe liver/kidney disease
Monitor blood glucose regularly, especially during dose adjustments or lifestyle changes
Use cautiously in elderly patients or those with malnutrition, as they are more susceptible to hypoglycemia
Inform your healthcare provider about other medications, as drug interactions can occur with gemfibrozil, NSAIDs, or other hypoglycemic agents
Pregnant or breastfeeding women should use only under medical supervision
Store in a cool, dry place below 30°C, away from light and moisture. Keep out of reach of children.
Glimet Tablet 1 mg (Repaglinide) is a fast-acting oral therapy for type 2 diabetes, offering effective postprandial glucose control, flexible dosing, and reduced hypoglycemia risk under proper medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet